#triglyceridelevels hashtag - Bluesky

@pharmaphorum.bsky.social

8 months ago

Sanofi grabs Chinese rights to Arrowhead rare disease drug Sanofi has paid $130 million upfront for Chinese rights to an Arrowhead Pharma drug for rare disease familial chylomicronaemia syndrome.

The importance of #China as a growth market for #pharma multinationals is underlined by the news that #Sanofi has paid $130 million upfront for Chinese rights to an #ArrowheadPharma drug under review for a disease associated with elevated #triglyceridelevels.

pharmaphorum.com/news/sanofi-...